Those of you who care enough know how Obama has stacked the FDA and USDA with Monsanto cronies, even after using his false stance of labeling GMOs to get elected the first time. Even Wall Street is well represented in the Treasury Department for bailout ease.
The trend continues to worsen with the latest stir about Obama’s nominee of choice to head the FDA soon, Robert M. Califf, MD, who formed the Duke (university) Translational Medicine Institute to speed up drug approvals. As part of that institute working hand in glove with the pharmaceutical industry, Califf benefited financially from Big Pharma directly and indirectly.
It wasn’t just grant money for research, a fair amount of Big Pharma funding augmented his salary as well.